sever
acut
respiratori
syndrom
sar
emerg
diseas
first
report
guangdong
provinc
china
late
diseas
rapidli
spread
least
countri
within
month
first
appear
concert
worldwid
effort
led
identif
etiolog
agent
sar
coronaviru
sarscov
novel
member
famili
coronavirida
complet
genom
sequenc
sarscov
confirm
pathogen
close
relat
previous
establish
coronaviru
group
bud
sarscov
occur
golgi
apparatu
result
incorpor
envelop
spike
glycoprotein
virion
spike
glycoprotein
type
membran
protein
facilit
viral
attach
cellular
receptor
initi
infect
angiotensinconvert
identifi
function
cellular
receptor
sarscov
recent
shown
process
spike
protein
effect
furinlik
convertas
inhibit
cleavag
specif
inhibitor
abrog
cytopath
significantli
reduc
viru
titer
sarscov
due
sever
sarscov
infect
potenti
rapid
spread
diseas
absenc
proven
effect
safe
vivo
inhibitor
viru
import
identifi
drug
effect
use
treat
prevent
potenti
sarscov
infect
mani
novel
therapeut
approach
evalu
laboratori
studi
sarscov
notabl
among
approach
use
sirna
passiv
antibodi
transfer
dna
vaccin
vaccinia
parainfluenza
viru
express
spike
protein
interferon
monoclon
antibodi
spike
glycoprotein
block
receptor
bind
report
describ
identif
chloroquin
effect
pre
postinfect
antivir
agent
sarscov
chloroquin
identifi
weak
base
increas
ph
acid
vesicl
ad
extracellularli
nonproton
portion
chloroquin
enter
cell
becom
proton
concentr
acid
lowph
organel
endosom
golgi
vesicl
lysosom
chloroquin
affect
viru
infect
mani
way
antivir
effect
depend
part
extent
viru
util
endosom
entri
chloroquin
wide
use
treat
human
diseas
malaria
amoebiosi
hiv
autoimmun
diseas
without
signific
detriment
side
effect
togeth
data
present
show
viru
inhibit
cell
cultur
chloroquin
dose
compat
patient
treatment
featur
suggest
evalu
chloroquin
anim
model
sarscov
infect
would
warrant
progress
toward
find
effect
antivir
prevent
treatment
diseas
order
investig
chloroquin
might
prevent
sarscov
infect
permiss
vero
cell
pretreat
variou
concentr
chloroquin
h
prior
viru
infect
cell
infect
sarscov
viru
antigen
visual
indirect
immunofluoresc
describ
materi
method
microscop
examin
fig
control
cell
untreat
infect
reveal
extens
sarscovspecif
immunostain
monolay
dosedepend
decreas
viru
antigenposit
cell
observ
start
chloroquin
concentr
complet
abolish
sarscov
infect
quantit
purpos
count
number
cell
stain
posit
three
random
locat
slide
averag
number
posit
stain
control
cell
score
compar
number
posit
cell
observ
variou
chloroquin
concentr
fig
pretreat
chloroquin
reduc
infect
respect
reproduc
result
obtain
three
independ
experi
data
demonstr
pretreat
vero
cell
chloroquin
render
cell
refractori
sarscov
infect
order
investig
antivir
properti
chloroquin
sarscov
initi
infect
vero
cell
infect
viru
fresh
medium
supplement
variou
concentr
chloroquin
ad
immedi
viru
adsorpt
infect
cell
incub
addit
h
presenc
viru
antigen
analyz
indirect
immunofluoresc
analysi
chloroquin
ad
initi
infect
dramat
dosedepend
decreas
number
viru
antigenposit
cell
fig
littl
chloroquin
reduc
infect
inhibit
observ
concentr
fig
concentr
chloroquin
excess
small
number
individu
cell
initi
infect
spread
infect
adjac
cell
elimin
halfmaxim
inhibitori
effect
estim
occur
chloroquin
fig
data
clearli
show
addit
chloroquin
effect
reduc
establish
infect
spread
sarscov
drug
ad
immedi
follow
viru
adsorpt
electron
microscop
analysi
indic
appear
signific
amount
extracellular
viru
particl
h
infect
sinc
observ
antivir
effect
chloroquin
immedi
viru
adsorpt
extend
analysi
ad
chloroquin
h
viru
adsorpt
examin
presenc
viru
antigen
h
found
chloroquin
still
significantli
effect
even
ad
h
infect
fig
howev
obtain
equival
antivir
effect
higher
concentr
chloroquin
requir
drug
ad
h
adsorpt
sinc
chloroquin
inhibit
sarscov
infect
ad
infect
hypothes
anoth
common
lysosomotrop
agent
might
also
function
similar
manner
ammonium
chlorid
wide
use
studi
address
endosomemedi
viru
entri
coincid
recent
shown
reduc
transduct
pseudotyp
virus
decor
sarscov
spike
protein
attempt
examin
function
similarli
chloroquin
perform
infect
analys
vero
cell
fig
fig
treat
variou
concentr
case
observ
inhibit
mm
data
indic
mm
chloroquin
effect
reduc
sarscov
infect
result
suggest
effect
chloroquin
control
sar
cov
infect
spread
might
mediat
similar
mechan
perform
addit
experi
elucid
mechan
sarscov
inhibit
chloroquin
sinc
intravesicular
acid
ph
regul
cellular
function
includ
nglycosyl
trim
cellular
traffick
variou
enzymat
activ
interest
character
effect
drug
process
glycosyl
cellular
sort
sarscov
spike
glycoprotein
receptor
flow
cytometri
analysi
perform
vero
cell
either
untreat
treat
highli
effect
antisarscov
concentr
chloroquin
result
reveal
neither
drug
caus
signific
chang
level
cellsurfac
indic
observ
inhibitori
effect
sarscov
infect
due
lack
avail
cellsurfac
fig
next
analyz
molecular
form
endogen
untreat
vero
cell
cell
preincub
h
variou
concentr
either
mm
chloroquin
label
met
h
presenc
absenc
drug
fig
normal
condit
observ
two
immunoreact
form
migrat
kda
respect
fig
lane
protein
endoglycosidas
h
sensit
suggest
repres
endoplasm
reticulum
er
local
form
wherea
protein
endoglycosidas
h
resist
repres
golgimodifi
form
specif
antibodi
confirm
displac
immunoreact
protein
band
excess
coldsolubl
human
recombin
fig
lane
analyz
form
presenc
clear
stepwis
increas
migrat
protein
observ
increas
concentr
maxim
effect
observ
mm
result
er
form
visibl
gel
fig
compar
lane
suggest
trim
andor
termin
modif
nglycosyl
chain
affect
treatment
addit
mm
er
form
migrat
slightli
faster
mobil
indic
concentr
might
also
affect
core
glycosyl
also
examin
termin
glycosyl
statu
cell
treat
chloroquin
fig
similar
stepwis
increas
electrophoret
mobil
observ
increas
concentr
chloroquin
chloroquin
faster
electrophoret
mobil
golgimodifi
form
clearli
evid
basi
flow
cytometri
immunoprecipit
analys
infer
chloroquin
impair
termin
glycosyl
result
dramat
effect
although
express
similar
quantiti
cell
surfac
variat
glycosyl
statu
might
render
interact
less
effici
inhibit
viru
entri
cell
treat
chloroquin
confirm
undergo
termin
sugar
modif
termin
glycosyl
affect
chloroquin
treatment
perform
immunopreipit
subject
immunoprecipit
neuraminidas
digest
protein
resolv
use
sdspage
fig
evid
slightli
faster
mobil
golgi
form
neuraminidas
treatment
fig
compar
lane
undergo
termin
glycosyl
howev
er
form
affect
neuraminidas
cell
treat
chloroquin
result
signific
shift
wherea
chloroquin
caus
golgi
form
resolv
similar
neuraminidasetr
fig
compar
lane
data
provid
evid
undergo
termin
glycosyl
chloroquin
antisarscov
concentr
abrog
process
next
address
whether
lysosomotrop
drug
chloroquin
affect
biosynthesi
glycosyl
andor
traffick
sarscov
spike
glycoprotein
purpos
vero
cell
infect
sarscov
h
chloroquin
ammonium
chlorid
ad
cell
starv
h
label
min
chase
h
cell
lysat
analyz
immunoprecipit
sarsspecif
polyclon
antibodi
hmaf
puls
result
indic
prospik
pro
synthes
precursor
proser
process
protein
fig
lane
result
ident
previou
analysi
except
chloroquin
fig
lane
signific
differ
biosynthesi
process
viru
spike
protein
untreat
chloroquinetr
cell
fig
lane
note
chloroquin
result
overal
decreas
biosynthesi
level
process
viru
glycoprotein
view
lack
reduct
biosynthesi
process
spike
glycoprotein
presenc
chloroquin
concentr
caus
larg
reduct
sarscov
replic
spread
conclud
antivir
effect
probabl
due
alter
viru
glycoprotein
biosynthesi
process
similar
analys
perform
data
suggest
biosynthesi
process
spike
protein
also
neg
affect
fig
lane
consist
previou
analysi
observ
presenc
larger
protein
refer
oligom
recent
song
et
al
provid
evid
homotrim
sarscov
spike
protein
incorpor
virion
interestingli
level
homotrim
cell
treat
chloroquin
mm
fig
lane
slightli
lower
control
cell
cell
treat
lower
drug
concentr
data
obtain
puls
follow
chase
fig
lane
confirm
earlier
observ
sarscov
spike
protein
precursor
proser
acquir
golgispecif
modif
prosgolgi
result
protein
chloroquin
substanti
neg
impact
appear
golgi
form
fig
compar
lane
lane
chloroquin
reduct
level
golgimodifi
prospik
observ
lane
hand
abrog
appear
golgimodifi
form
mm
compar
lane
milder
effect
mm
lane
data
clearli
demonstr
biosynthesi
proteolyt
process
sarscov
spike
protein
affect
chloroquin
mm
dose
caus
viru
inhibitori
effect
addit
mm
increas
accumul
proser
concomit
decreas
amount
oligom
fig
lane
examin
homotrim
found
chloroquin
mm
result
slightli
faster
mobil
trimer
fig
lane
lower
drug
dose
exhibit
signific
antivir
effect
result
appreci
differ
data
suggest
newli
synthes
intracellular
spike
protein
may
major
target
chloroquin
antivir
action
faster
mobil
trimer
certain
higher
concentr
drug
might
due
effect
drug
termin
glycosyl
trimer
identifi
chloroquin
effect
antivir
agent
sarscov
cell
cultur
condit
evidenc
inhibitori
effect
drug
ad
prior
infect
initi
establish
infect
fact
chloroquin
exert
antivir
effect
pre
postinfect
condit
suggest
like
prophylact
therapeut
advantag
recent
keyaert
et
al
report
antivir
properti
chloroquin
identifi
drug
affect
sarscov
replic
cell
cultur
evidenc
quantit
rtpcr
taken
togeth
find
keyaert
et
al
analysi
provid
evid
chloroquin
effect
sarscov
frankfurt
urbani
strain
provid
evid
chloroquin
effect
prevent
sarscov
infect
cell
cultur
drug
ad
cell
h
prior
infect
addit
chloroquin
significantli
effect
even
drug
ad
h
infect
suggest
antivir
effect
even
establish
infect
sinc
similar
result
obtain
treatment
vero
cell
underli
mechan
action
drug
might
similar
apart
probabl
role
chloroquin
sarscov
replic
mechan
action
chloroquin
sarscov
fulli
understood
previou
studi
suggest
elev
ph
mechan
chloroquin
reduc
transduct
sarscov
pseudotyp
virus
examin
effect
chloroquin
sarscov
spike
protein
receptor
immunoprecipit
result
clearli
demonstr
effect
antisarscov
concentr
chloroquin
also
impair
termin
glycosyl
howev
flow
cytometri
data
demonstr
signific
differ
cell
surfac
express
cell
treat
chloroquin
basi
result
reason
suggest
pretreat
chloroquin
possibl
result
surfac
express
underglycosyl
case
chloroquin
treatment
prior
infect
impair
termin
glycosyl
may
result
reduc
bind
affin
sarscov
spike
protein
neg
influenc
initi
sarscov
infect
sinc
biosynthesi
process
golgi
modif
oligomer
newli
synthes
spike
protein
appreci
affect
antisarscov
concentr
either
chloroquin
conclud
event
occur
cell
independ
presenc
drug
potenti
contribut
drug
elev
endosom
ph
impact
subsequ
viru
entri
exit
could
rule
decreas
sarscov
pseudotyp
transduct
presenc
observ
attribut
effect
intracellular
ph
chloroquin
ad
infect
agent
rapidli
rais
ph
subvert
ongo
fusion
event
viru
endosom
thu
inhibit
infect
addit
mechan
action
chloroquin
might
depend
ad
cell
ad
initi
infect
drug
might
affect
endosomemedi
fusion
subsequ
viru
replic
assembl
releas
previou
studi
chloroquin
demonstr
multipl
effect
mammalian
cell
addit
elev
endosom
ph
includ
prevent
termin
glycosyalt
immunoglobulin
ad
virusinfect
cell
chloroquin
inhibit
later
stage
vesicular
stomat
viru
matur
inhibit
glycoprotein
express
cell
surfac
inhibit
product
infecti
particl
interf
termin
glycosyl
glycoprotein
basi
properti
suggest
cell
surfac
express
underglycosyl
poor
affin
sarscov
spike
protein
may
primari
mechan
infect
prevent
drug
pretreat
cell
prior
infect
hand
rapid
elev
endosom
ph
abrog
virusendosom
fusion
may
primari
mechan
viru
infect
prevent
posttreat
condit
detail
sar
cov
bind
assay
presenc
absenc
chloroquin
perform
confirm
find
studi
indic
impact
chloroquin
spike
protein
profil
significantli
differ
exhibit
pronounc
effect
chloroquin
termin
glycosyl
highlight
novel
intric
differ
chloroquin
ammonium
chlorid
affect
protein
transport
glycosyl
sarscov
spike
protein
receptor
despit
wellestablish
similar
effect
endosom
ph
elev
infect
coronavirus
sarscov
also
affect
chloroquin
exemplifi
human
inhibitori
effect
observ
sarscov
infect
cell
spread
occur
presenc
chloroquin
plasma
concentr
achiev
prophylaxi
treatment
malaria
vari
henc
well
toler
patient
recent
specul
chloroquin
might
effect
sar
author
suggest
compound
might
block
product
data
provid
evid
possibl
use
wellestablish
drug
chloroquin
clinic
manag
sar
chloroquin
rel
safe
effect
cheap
drug
use
treat
mani
human
diseas
includ
malaria
amoebiosi
human
immunodefici
viru
effect
inhibit
infect
spread
sar
cov
cell
cultur
fact
drug
signific
inhibitori
antivir
effect
suscept
cell
treat
either
prior
infect
suggest
possibl
prophylact
therapeut
use
vero
cell
african
green
monkey
kidney
cell
line
infect
sarscov
urbani
strain
multipl
infect
h
cell
wash
pb
incub
optimem
invitrogen
medium
without
variou
concentr
either
chloroquin
sigma
immunofluoresc
stain
perform
sarscovspecif
hyperimmun
mous
ascit
fluid
hmaf
follow
antimous
fluoresceincoupl
antibodi
eighteen
hour
infect
viruscontain
supernat
remov
cell
puls
cy
min
chase
h
lysi
ripa
buffer
clarifi
cell
lysat
media
incub
hmaf
immunoprecipit
protein
separ
nupag
gel
invitrogen
protein
visual
autoradiographi
experi
cell
chase
h
isotopefre
medium
clarifi
cell
supernat
also
immunoprecipit
sarscovspecif
hmaf
vero
cell
seed
dulbecco
modifi
eagl
medium
invitrogen
supplement
fetal
bovin
serum
next
day
cell
incub
optimem
invitrogen
presenc
absenc
chloroquin
mm
analyz
level
cell
surfac
cell
incub
ice
affinitypurifi
goat
antibodi
r
system
incub
fitclabel
swine
antigoat
igg
antibodi
caltag
laboratori
label
cell
analyz
flow
cytometri
facscalibur
flow
cytomet
bd
bioscienc
biosynthesi
studi
vero
cell
puls
met
perkin
elmer
h
indic
concentr
chloroquin
lyse
ripa
buffer
clarifi
lysat
immunoprecipit
affinitypurifi
goat
antibodi
r
system
immunoprecipit
protein
separ
sdspolyacrylamid
gel
electrophoresi
author
declar
compet
interest
mv
experi
pertain
sar
cov
infect
coordin
draft
manuscript
eb
sb
perform
experi
biosynthesi
fac
analysi
perform
data
acquisit
immunofluoresc
experi
pr
tk
provid
critic
reagent
revis
manuscript
critic
ns
sn
along
mv
eb
particip
plan
experi
review
interpret
data
critic
review
manuscript
author
read
approv
content
manuscript
